121 related articles for article (PubMed ID: 16122195)
1. Radiation enhances cisplatin-sensitivity in human cervical squamous cancer cells in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2005; 26(4):431-3. PubMed ID: 16122195
[TBL] [Abstract][Full Text] [Related]
2. Effects of mitomycin C on radiation-induced cell death in human cervical squamous cell carcinomas.
Tanaka T; Umesaki N
Eur J Gynaecol Oncol; 2005; 26(4):411-4. PubMed ID: 16122190
[TBL] [Abstract][Full Text] [Related]
3. Effective chemoradiotherapy protocol with 5-fluorouracil for cervical squamous cell carcinoma in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2006; 27(3):243-6. PubMed ID: 16800250
[TBL] [Abstract][Full Text] [Related]
4. Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2006 Apr; 15(4):939-47. PubMed ID: 16525683
[TBL] [Abstract][Full Text] [Related]
5. Radiation reduces pirarubicin sensitivity in human cervical squamous cell carcinoma cells.
Tanaka T; Umesaki N
Oncol Rep; 2005 Jun; 13(6):1165-8. PubMed ID: 15870938
[TBL] [Abstract][Full Text] [Related]
6. Combination effects of irradiation and irinotecan on cervical squamous cell carcinoma cells in vitro.
Tanaka T; Yukawa K; Umesaki N
Oncol Rep; 2005 Nov; 14(5):1365-9. PubMed ID: 16211310
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
Bai T; Tanaka T; Yukawa K; Umesaki N
Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
[TBL] [Abstract][Full Text] [Related]
8. Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2007; 28(5):352-5. PubMed ID: 17966212
[TBL] [Abstract][Full Text] [Related]
9. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution.
Kinjyo Y; Nagai Y; Toita T; Kudaka W; Ariga T; Shimoji Y; Nakasone T; Taira Y; Arakaki Y; Nakamoto T; Wakayama A; Ooyama T; Maemoto H; Heianna J; Aoki Y
Br J Radiol; 2017 Aug; 90(1076):20170241. PubMed ID: 28707541
[TBL] [Abstract][Full Text] [Related]
10. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
[TBL] [Abstract][Full Text] [Related]
12. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
[TBL] [Abstract][Full Text] [Related]
13. Preliminary estimation of treatment effect on uterine cervical squamous cell carcinoma in terms of tumor regression rate: comparison between chemoradiotherapy and radiotherapy alone.
Ohara K; Tanaka YO; Tsunoda H; Oki A; Satoh T; Onishi K; Kagei K; Sugahara S; Hata M; Igaki H; Tokuuye K; Akine Y; Yoshikawa H
Radiat Med; 2005 Feb; 23(1):25-9. PubMed ID: 15786748
[TBL] [Abstract][Full Text] [Related]
14. Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Utsunomiya T; Umesaki N
Oncol Rep; 2005 Oct; 14(4):941-8. PubMed ID: 16142355
[TBL] [Abstract][Full Text] [Related]
15. Irradiation reduces bleomycin sensitivity in cervical squamous cancer cells in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2007; 28(4):273-7. PubMed ID: 17713091
[TBL] [Abstract][Full Text] [Related]
16. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma.
Jones EL; Samulski TV; Dewhirst MW; Alvarez-Secord A; Berchuck A; Clarke-Pearson D; Havrilesky LJ; Soper J; Prosnitz LR
Cancer; 2003 Jul; 98(2):277-82. PubMed ID: 12872345
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-up.
Nagy VM; Ordeanu C; Coza O; Alin CR; Traila A; Todor N
Int J Gynecol Cancer; 2012 Nov; 22(9):1538-44. PubMed ID: 23070071
[TBL] [Abstract][Full Text] [Related]
18. Out-of-protocol concurrent use of cisplatin and radiation therapy in locally advanced cervical cancer: feasibility and survival.
Mancebo G; Gil-Moreno A; Vergés R; Martínez-Palones JM; Checa MA; Carreras JM; Giralt J; Xercavins J
Eur J Gynaecol Oncol; 2010; 31(1):18-22. PubMed ID: 20349775
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
